Valuation Changchun BCHT Biotechnology Co.

Equities

End-of-day quote Shanghai S.E. Other stock markets 2025-01-21			5-day change	1st Jan Change
22.91 ^CNY	-0.82%		-3.50%	-8.76%

10-25	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
08-16	Changchun BCHT Biotechnology H1 Profit Up 24%, Operating Income Rises 11%	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Capitalization ¹	28,321	28,531	22,628	9,477	9,477	-
Change	-	0.74%	-20.69%	-58.12%	0%	-
Enterprise Value (EV)	28,321	28,531	22,628	9,477	9,477	9,477
Change	-	0.74%	-20.69%	-58.12%	0%	0%
P/E ratio	111x	157x	45.3x	13.7x	12.6x	9.71x
PBR	8.29x	8.02x	5.63x	2.1x	1.81x	1.55x
PEG	-2.4x	-5.4x	0x	0.4x	1.38x	0.3x
Capitalization / Revenue	23.6x	26.6x	12.4x	4.81x	3.82x	3.2x
EV / Revenue	0x	0x	0x	4.81x	3.82x	3.2x
EV / EBITDA	0x	0x	0x	13x	9.74x	7.7x
EV / EBIT	0x	0x	0x	16x	11.1x	8.66x
EV / FCF	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-
Dividend per Share ²	-	0.15	0.15	0.1633	0.1967	0.24
Rate of return	-	0.22%	0.27%	0.71%	0.86%	1.05%
EPS ²	0.62	0.44	1.21	1.67	1.822	2.36
Distribution rate	-	34.1%	12.4%	9.78%	10.8%	10.2%
Net sales ¹	1,202	1,071	1,825	1,971	2,480	2,958
EBITDA ¹	331.2	263.5	651.3	729	973.4	1,230
EBIT ¹	261.9	187	559.3	592.5	850.2	1,095
Net income ¹	243.6	181.6	501	527	753.4	975.1
Net Debt	-	-	-	-	-	-
Reference price ²	68.60	69.11	54.81	22.91	22.91	22.91
Nbr of stocks (in thousands)	412,841	412,841	412,841	413,658	413,658	-
Announcement Date	2/18/22	2/24/23	2/23/24	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield	Capi. ($)
CHANGCHUN BCHT BIOTECHNOLOGY CO.	13.72x	-	-	+0.71%	1.3B
MERCK KGAA	21.5x	3.31x	11.57x	+1.62%	65.27B
KYOWA KIRIN CO. LTD.	17.52x	1.72x	7.44x	+2.53%	7.48B
HALOZYME THERAPEUTICS, INC.	16.54x	8.39x	13.66x	-	7.12B
YUHAN CORPORATION	80.23x	4.72x	60x	+0.32%	6.87B
SK BIOPHARMACEUTICALS CO., LTD.	126.63x	15.58x	83.82x	-.--%	5.87B
BETTA PHARMACEUTICALS CO., LTD.	45.24x	8.31x	24.24x	+0.48%	3.28B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	13.32x	-	-	+0.86%	2.14B
SUPERNUS PHARMACEUTICALS, INC.	36.74x	-	-	-	2.13B
Average	41.27x	7.00x	33.45x	+0.93%	11.27B
Weighted average by Cap.	31.74x	4.58x	19.73x	+1.42%